MHE March 2020

The successor, Oncology Care First, will likely include two tracks with downside risk right from the start.

Medicare Advantage plans are now covering more benefits than they have in the past for those facing social determinants of health in their daily lifestyles.

There is fairly broad agreement that conditions like cancer, diabetes, and more will be the most costly for the American healthcare system over the next decade.

While it is a common understanding that too much of the $3.6 trillion we spend on healthcare is not wisely spent, there are opportunities for the industry to make some changes.

Managed Healthcare Executive asked thought leaders: “What apps do you use the most on your phone?” Here’s what they said.

DMARDs and the JAK Inhibitors have improved RA treatment. But not many new drugs are in the offing at the moment.

How two hospitals and two insurers are working to turn the tide of the opioid epidemic.

A look at the president and CEO's experience in becoming an influential reason for Intermountain Healthcare's success.

New point-of-care tools offer greater transparency.